2015
Causes of Death among AIDS Patients after Introduction of Free Combination Antiretroviral Therapy (cART) in Three Chinese Provinces, 2010–2011
Wang L, Ge L, Wang L, Morano JP, Guo W, Khoshnood K, Qin Q, Ding Z, Sun D, Liu X, Luo H, Tillman J, Cui Y. Causes of Death among AIDS Patients after Introduction of Free Combination Antiretroviral Therapy (cART) in Three Chinese Provinces, 2010–2011. PLOS ONE 2015, 10: e0139998. PMID: 26506621, PMCID: PMC4624241, DOI: 10.1371/journal.pone.0139998.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAgedAntiretroviral Therapy, Highly ActiveCause of DeathChinaDrug Therapy, CombinationFemaleHumansMaleMiddle AgedRisk FactorsConceptsCombination antiretroviral therapyCause of deathCells/mm3AIDS patientsCD4 countCombination anti-retroviral therapyDeceased AIDS patientsNational HIV RegistryAnti-retroviral therapyInjury-related deathsCross-sectional surveyCause of AIDSCART initiationHIV RegistryAntiretroviral therapyART-naïveHIV diagnosisDisease burdenMedical recordsChi-square analysisAverage agePatientsART statusLogistic regressionAIDS
2005
Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran
Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, Masjedi H, Zahirifard S, Mohammadi F, Farnia P, Masjedi MR, Velayati AA. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. International Journal Of Infectious Diseases 2005, 9: 317-322. PMID: 16183321, DOI: 10.1016/j.ijid.2004.09.012.Peer-Reviewed Original ResearchConceptsMultiple drug-resistant tuberculosisMore second-line drugsDrug-resistant tuberculosis treatmentMDR-TB patientsMDR-TB treatmentMasih Daneshvari HospitalDrug-resistant tuberculosisSecond-line drugsAppropriate treatment regimensProbable cureDrug regimenTreatment regimenComplete followTreatment regimensTuberculosis treatmentPatientsAverage durationRegimenTreatmentDrugsCureRegimensAmikacinHospitalFollow